Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0S0EK
|
||||
| Former ID |
DNC009079
|
||||
| Drug Name |
CCDC 710249, HCl salt
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Discovery agent | Investigative | [530013] | ||
| Structure |
|
Download |
|||
| Formula |
C21H27ClN2O4
|
||||
| Canonical SMILES |
C1CC1CN2CCC34CC(=O)CCC3(C2CC5=C4C(=C(C=C5)C(=O)N)O)O.Cl
|
||||
| InChI |
1S/C21H26N2O4.ClH/c22-19(26)15-4-3-13-9-16-21(27)6-5-14(24)10-20(21,17(13)18(15)25)7-8-23(16)11-12-1-2-12;/h3-4,12,16,25,27H,1-2,5-11H2,(H2,22,26);1H/t16-,20-,21-;/m1./s1
|
||||
| InChIKey |
LRMKVAABEFFIDK-GPCMIKKWSA-N
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Kappa-type opioid receptor | Target Info | Inhibitor | [530013] | |
| Delta-type opioid receptor | Target Info | Inhibitor | [530013] | ||
| Mu-type opioid receptor | Target Info | Inhibitor | [530013] | ||
| NetPath Pathway | TCR Signaling Pathway | ||||
| PANTHER Pathway | Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | ||||
| Heterotrimeric G-protein signaling pathway-Gq alpha and Go alpha mediated pathway | |||||
| Opioid prodynorphin pathwayP00026:Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | |||||
| Enkephalin release | |||||
| Opioid proenkephalin pathway | |||||
| Opioid proopiomelanocortin pathwayP00026:Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | |||||
| Pathway Interaction Database | IL4-mediated signaling events | ||||
| References | |||||